Hep-Net

HepNet, primarily operating through the HepNet Study House under the German Liver Foundation, is a specialized clinical research organization and scientific network focused on liver diseases. The organization coordinates large-scale multicenter clinical trials, registries, and academic research projects specifically targeting viral hepatitis (B, C, and D), liver cirrhosis, and hepatocellular carcinoma. By bridging the gap between academic research and clinical application, HepNet provides infrastructure for drug development and long-term patient monitoring. It serves as a central hub for hepatology expertise in Europe, collaborating with pharmaceutical partners to conduct Phase 2 through Phase 4 clinical trials.